摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl N-benzyloxycarbonyl-2-deoxy-3,6-di-O-benzylglucopyranoside | 110236-56-1

中文名称
——
中文别名
——
英文名称
methyl N-benzyloxycarbonyl-2-deoxy-3,6-di-O-benzylglucopyranoside
英文别名
CbzNH(-2d)[Bn(-3)][Bn(-6)]a-Glc1Me;benzyl N-[(2S,3R,4R,5S,6R)-5-hydroxy-2-methoxy-4-phenylmethoxy-6-(phenylmethoxymethyl)oxan-3-yl]carbamate
methyl N-benzyloxycarbonyl-2-deoxy-3,6-di-O-benzylglucopyranoside化学式
CAS
110236-56-1
化学式
C29H33NO7
mdl
——
分子量
507.584
InChiKey
ASQNDICQCVNVEF-FXGKLIOSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    37
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.34
  • 拓扑面积:
    95.5
  • 氢给体数:
    2
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • An efficient synthesis of l-idose and l-iduronic acid thioglycosides and their use for the synthesis of heparin oligosaccharides
    作者:János Tatai、Györgyi Osztrovszky、Mária Kajtár-Peredy、Péter Fügedi
    DOI:10.1016/j.carres.2007.12.015
    日期:2008.3
    preparations of thioglycoside derivatives of L-idose and L-iduronic acid are described. The method avoids the tedious chromatographic separations of furanose and pyranose anomeric mixtures, and affords the thioglycosides in a stereoselective manner. The L-idose and L-iduronic acid thioglycosides having combinations of different protecting groups proved to be efficient glycosyl donors in the synthesis of heparin
    描述了L-异糖和L-艾杜糖醛酸的硫代糖苷衍生物的有效制剂。该方法避免了呋喃糖和吡喃糖异头混合物的繁琐色谱分离,并以立体选择性方式提供了硫糖苷。具有不同保护基的组合的L-异糖和L-艾杜糖醛酸硫糖苷被证明是肝素二糖合成中有效的糖基供体。
  • A Modular Strategy Toward the Synthesis of Heparin-like Oligosaccharides Using Monomeric Building Blocks in a Sequential Glycosylation Strategy
    作者:Jeroen D. C. Codée、Bas Stubba、Marialuisa Schiattarella、Herman S. Overkleeft、Constant A. A. van Boeckel、Jacques H. van Boom、Gijsbert A. van der Marel
    DOI:10.1021/ja045613g
    日期:2005.3.1
    A novel flexible assembly strategy is described for the modular synthesis of heparin and heparan sulfates. The reported strategy uses monomeric building blocks to construct the oligosaccharide chain to attain a maximum degree of flexibility. In the assembly, 1-hydroxyl glucosazido- and 1-thio uronic acid donors are combined in a sequential glycosylation protocol using sulfonium triflate activator systems
    描述了一种新的灵活组装策略,用于肝素和硫酸乙酰肝素的模块化合成。报道的策略使用单体构建块来构建寡糖链以获得最大程度的灵活性。在组装中,使用三氟甲磺酸锍激活剂系统将 1-羟基葡糖叠氮基和 1-硫代糖醛酸供体结合在连续糖基化方案中。关键的 1-硫代糖醛酸是以有效的方式从双丙酮葡萄糖中获得的,采用部分保护的葡萄糖和艾糖硫糖苷的化学和区域选择性氧化。
  • Preparation of 1-Thio Uronic Acid Lactones and Their Use in Oligosaccharide Synthesis
    作者:Leendert J. van den Bos、Remy E. J. N. Litjens、Richard J. B. H. N. van den Berg、Herman S. Overkleeft、Gijsbert A. van der Marel
    DOI:10.1021/ol050491y
    日期:2005.5.1
    TEMPO/BAIB-mediated oxidation of 2,6- and 3,6-dihydroxy 1-thio glycopyranosides to the corresponding 1-thio uronic acid lactones is described. These locked 1-thio glycuronides can directly be used as donors in glycosidation reactions using the Ph(2)SO/Tf(2)O reagent system. Alternatively, selective opening of the lactone bridge liberates a hydroxyl function for ensuing glycosylations.
    描述了由化学和区域选择性的TEMPO / BAIB介导的2,6-和3,6-二羟基1-硫代糖吡喃糖苷氧化为相应的1-硫代糖醛酸内酯。使用Ph(2)SO / Tf(2)O试剂系统,可以将这些锁定的1-硫代乙二醛糖醛酸酯直接用作糖苷化反应中的供体。可替代地,内酯桥的选择性开放释放了用于随后糖基化的羟基功能。
  • 一种抗凝血药物磺达肝癸钠单糖片段中间体 的制备方法
    申请人:重庆大学
    公开号:CN105175460B
    公开(公告)日:2017-12-01
    本发明提供了一种单糖中间体的制备方法,所述中间体可用于抗凝血药物磺达肝癸钠的制备。本发明所述方法操作简单,可实现单一光学活性的磺达肝癸钠单糖片段A中间体的公斤级制备,解决了现有现有磺达肝癸钠A片段合成的技术瓶颈,适于工业化生产。
  • Synthesis of heparin partial structures and their binding activities to platelets
    作者:Shuhei Koshida、Yasuo Suda、Michael Sobel、Julie Ormsby、Shoichi Kusumoto
    DOI:10.1016/s0960-894x(99)00550-8
    日期:1999.11
    A synthetic pentasaccharide corresponding to the antithrombin III-binding region in heparin was also found to bind to human platelets. To identify the platelet-binding site in the pentasaccharide which is expected to be a novel sequence in heparin responsible for its platelet-binding, five partial structures of this particular pentasaccharide were synthesized. In a competitive assay using [H-3]-heparin, a trisaccharide, O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glucopyranosyl)-(1-->4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-->4)-2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranose, was concluded to be a high-affinity site for heparin's binding to platelets. (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多